LILRB4 STAR-T Cells in the Treatment of Relapsed/Refractory Acute Myeloid Leukemia

NCT05518357 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
2
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Hebei Yanda Ludaopei Hospital